After recovering from Covid-19 in April, Tom Hanks was so chuffed by the prospect of his plasma being used for medical science that he suggested calling the results a “Hank-cine.” He is not alone. Other former patients are equally enthusiastic about donating blood to the research effort. “They are very willing and motivated,” says Gerald Lee, chief product officer at Sanguine Biosciences, a business that enables patient participation in medical research. “They want to make a difference in finding a treatment.”
Read the entire article here.